Cargando…

Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study

BACKGROUND: Nonpersistence in anticoagulation therapy is common and associated with undesirable clinical outcomes in patients with venous thromboembolism (VTE). METHODS: We investigated preceding clinical events of treatment nonpersistence (e.g., switching, discontinuing, or restarting) in VTE patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Dongwon, Jeong, Han Eol, Choi, Songhwa, Lee, Daye, Shin, Ju‐Young, Bang, Soo‐Mee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660092/
https://www.ncbi.nlm.nih.gov/pubmed/37882319
http://dx.doi.org/10.1002/cam4.6626
_version_ 1785137688645468160
author Yoon, Dongwon
Jeong, Han Eol
Choi, Songhwa
Lee, Daye
Shin, Ju‐Young
Bang, Soo‐Mee
author_facet Yoon, Dongwon
Jeong, Han Eol
Choi, Songhwa
Lee, Daye
Shin, Ju‐Young
Bang, Soo‐Mee
author_sort Yoon, Dongwon
collection PubMed
description BACKGROUND: Nonpersistence in anticoagulation therapy is common and associated with undesirable clinical outcomes in patients with venous thromboembolism (VTE). METHODS: We investigated preceding clinical events of treatment nonpersistence (e.g., switching, discontinuing, or restarting) in VTE patients with and without active cancer using Korean claims database. RESULTS: Clinically significant events including thromboembolic events, hepatic function change and surgery preceded treatment nonpersistence, but heterogeneous distributions of clinical events were observed in the presence of active cancer. Patients with active cancer had a low rate of clinical events preceding treatment nonpersistence, and new active cancer diagnosis in the nonactive cancer group was most common before the switch to parenteral anticoagulants from warfarin or non‐vitamin K antagonist oral anticoagulants (NOACs). CONCLUSION: These findings suggest that clinically significant events can precede treatment nonpersistence and largely paralleled current guidelines for patients with VTE, whereas heterogeneous distributions of clinical events were observed in the presence of active cancer.
format Online
Article
Text
id pubmed-10660092
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106600922023-10-26 Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study Yoon, Dongwon Jeong, Han Eol Choi, Songhwa Lee, Daye Shin, Ju‐Young Bang, Soo‐Mee Cancer Med BRIEF COMMUNICATION BACKGROUND: Nonpersistence in anticoagulation therapy is common and associated with undesirable clinical outcomes in patients with venous thromboembolism (VTE). METHODS: We investigated preceding clinical events of treatment nonpersistence (e.g., switching, discontinuing, or restarting) in VTE patients with and without active cancer using Korean claims database. RESULTS: Clinically significant events including thromboembolic events, hepatic function change and surgery preceded treatment nonpersistence, but heterogeneous distributions of clinical events were observed in the presence of active cancer. Patients with active cancer had a low rate of clinical events preceding treatment nonpersistence, and new active cancer diagnosis in the nonactive cancer group was most common before the switch to parenteral anticoagulants from warfarin or non‐vitamin K antagonist oral anticoagulants (NOACs). CONCLUSION: These findings suggest that clinically significant events can precede treatment nonpersistence and largely paralleled current guidelines for patients with VTE, whereas heterogeneous distributions of clinical events were observed in the presence of active cancer. John Wiley and Sons Inc. 2023-10-26 /pmc/articles/PMC10660092/ /pubmed/37882319 http://dx.doi.org/10.1002/cam4.6626 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle BRIEF COMMUNICATION
Yoon, Dongwon
Jeong, Han Eol
Choi, Songhwa
Lee, Daye
Shin, Ju‐Young
Bang, Soo‐Mee
Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study
title Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study
title_full Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study
title_fullStr Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study
title_full_unstemmed Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study
title_short Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study
title_sort heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: a nationwide cohort study
topic BRIEF COMMUNICATION
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660092/
https://www.ncbi.nlm.nih.gov/pubmed/37882319
http://dx.doi.org/10.1002/cam4.6626
work_keys_str_mv AT yoondongwon heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy
AT jeonghaneol heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy
AT choisonghwa heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy
AT leedaye heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy
AT shinjuyoung heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy
AT bangsoomee heterogeneousdistributionsinclinicaleventsprecedinganticoagulanttreatmentnonpersistenceinpatientswithvenousthromboembolismstratifiedbyactivecanceranationwidecohortstudy